PPGN.SW
PolyPeptide Group AG
Price:  
40.50 
CHF
Volume:  
17,693.00
Switzerland | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PPGN.SW Relative Valuation

-57.7%
Upside

As of 2026-11-06, the Relative Valuation of PolyPeptide Group AG (PPGN.SW) is 17.14 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 40.50 CHF, the upside of PolyPeptide Group AG based on Relative Valuation is -57.7%.

The range of the Relative Valuation is 15.19 - 22.12 CHF.

Range Selected
Trailing P/E multiples 36.0x - 50.7x 40.2x
Forward P/E multiples 34.8x - 49.3x 38.4x
Fair Price 15.19 - 22.12 17.14
Upside -62.5% - -45.4% -57.7%
40.50 CHF
Stock Price
17.14 CHF
Fair Price

PPGN.SW Relative Valuation - Historical P/E Data

Date P/E
2026-11-05 92.85
2026-11-04 94.80
2026-11-03 97.66
2026-11-02 94.80
2026-10-30 96.29
2026-10-29 99.50
2026-10-28 100.19
2026-10-27 100.41
2026-10-26 100.41
2026-10-23 100.76
2026-10-22 101.22
2026-10-21 101.10
2026-10-20 100.99
2026-10-19 100.99
2026-10-16 100.76
2026-10-15 100.87
2026-10-14 101.10
2026-10-13 101.56
2026-10-12 100.76
2026-10-09 100.53
2026-10-08 100.64
2026-10-07 100.64
2026-10-06 100.99
2026-10-05 100.99
2026-10-02 101.10
2026-10-01 101.10
2026-09-30 101.10
2026-09-29 100.99
2026-09-28 101.10
2026-09-25 101.10
2026-09-24 101.22
2026-09-23 101.33
2026-09-22 101.10
2026-09-21 100.87
2026-09-18 100.87
2026-09-17 100.99
2026-09-16 101.10
2026-09-15 100.99
2026-09-14 100.87
2026-09-11 100.99
2026-09-10 100.87
2026-09-09 100.87
2026-09-08 100.87
2026-09-07 100.87
2026-09-04 100.76
2026-09-03 100.76
2026-09-02 100.99
2026-09-01 100.87
2026-08-31 100.99
2026-08-28 100.87